Pemtumomab
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Pemtumomab (trade name Theragyn) is a mouse monoclonal antibody used to treat cancer. The substance has affinity to various types of cancer, like ovarian cancer and peritoneal cancer, via the polymorphic epithelial mucin (PEM or MUC-1) and delivers the radioisotope Yttrium-90 into the tumour.[1] As of 2009[update]Script error: No such module "Check for unknown parameters"., it is undergoing Phase III clinical trials.[2]
It has been granted orphan drug status in Europe.[3]
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "Citation/CS1".
- ↑ Clinical trial number NCT00004115 for "Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy" at ClinicalTrials.gov
- ↑ Antisoma's Lead Product, Pemtumomab Granted European Orphan Drug StatusScript error: No such module "Unsubst".Template:Cbignore
Script error: No such module "Check for unknown parameters".
Template:Monoclonals for tumors Template:Asbox Template:Antineoplastic-drug-stub